Improvement in Liver Function and Non-Invasive Estimates of Liver Fibrosis 48 Weeks after Treatment With Ombitasvir/Paritaprevir/r, Dasabuvir, and Ribavirin in HCV Genotype 1 Patients With Cirrhosis

Press/Media: Press / Media

PeriodApr 24 2015

Media coverage

1

Media coverage

  • TitleImprovement in Liver Function and Non-Invasive Estimates of Liver Fibrosis 48 Weeks after Treatment With Ombitasvir/Paritaprevir/r, Dasabuvir, and Ribavirin in HCV Genotype 1 Patients With Cirrhosis
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date4/24/15
    PersonsFred Poordad